Overview
Overview
An open randomized phase i/ii study evaluating safety and immunogenicity of a candidate hiv-1 vaccine, mva.hiva, administered to healthy infants born to hiv-1-infected mothers
Principal Investigator
Principle Instigator
Prof Walter Jaoko
Abstract
Abstract
Safety and immunogenicity of MVA.HIVA vaccine in 20-week-old healthy Kenyan infants born to HIV-1-infected mothers.
